Invuity Closes on $25M Series D Financing
June 15, 2012- Share:
Invuity, a developer of surgical visualization and illumination technology for use in minimally invasive procedures, has landed its fifth round. The latest $25 million Series D financing brings the company's total funding up to $53.44 million. Valence Life Sciences led the round, investing through the Valence Advantage Life Sciences Fund II, and was joined by Kleiner Perkins Caufield & Byers, InterWest Partners and Wexford Capital.
- Share:
-
-
-
-